Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Schmidinger, M; Stager, G; Wenzel, C; Locker, GJ; Budinsky, AC; Brodowicz, T; Kramer, G; Marberger, M; Zielinski, CC
   Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial
   JOURNAL OF IMMUNOTHERAPY
   
   M. Schmidinger et al., "Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial", J IMMUNOTH, 24(3), 2001, pp. 257-262
2. Locker, GJ; Wenzel, C; Schmidinger, M; Gnant, MFX; Marosi, C; Jakesz, R; Zielinski, CC; Steger, GG
   Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients
   ANTI-CANCER DRUGS
   
   G.J. Locker et al., "Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients", ANTI-CANC D, 12(3), 2001, pp. 209-212
3. Schmidinger, M; Budinsky, AC; Wenzel, C; Locker, GJ; Pluschnig, U; Brodowicz, T; Kubista, E; Maca, S; Zabernigg, A; Ilsinger, P; Seewann, L; Hojas, S; Blach, M; Zielinski, CC; Steger, GG
   Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   M. Schmidinger et al., "Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial", CANC CHEMOT, 47(1), 2001, pp. 57-62
4. Traunmuller, F; Thalhammer-Scherrer, R; Locker, GJ; Losert, H; Schmid, R; Staudinger, T; Thalhammer, F
   Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients
   Journal of antimicrobial chemotherapy
   
   F. Traunmuller et al., "Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients", J ANTIMICRO, 47(2), 2001, pp. 229-231
5. Staudinger, T; Kofler, J; Mullner, M; Locker, GJ; Laczika, K; Knapp, S; Losert, H; Frass, M
   Comparison of prone positioning and continuous rotation of patients with adult respiratory distress syndrome: Results of a pilot study
   CRITICAL CARE MEDICINE
   
   T. Staudinger et al., "Comparison of prone positioning and continuous rotation of patients with adult respiratory distress syndrome: Results of a pilot study", CRIT CARE M, 29(1), 2001, pp. 51-56
6. Locker, GJ; Kofler, J; Stoiser, B; Wilfing, A; Wenzel, C; Wogerbauer, M; Steger, GC; Zielinski, CC; Mader, R; Burgmann, H
   Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2
   EUROPEAN CYTOKINE NETWORK
   
   G.J. Locker et al., "Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2", EUR CYTOKIN, 11(3), 2000, pp. 391-396
7. Stoiser, B; Thalhammer, F; El-Menyawi, I; Wilfing, A; Daxbock, F; Locker, GJ; Burgmann, H
   Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome
   CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
   
   B. Stoiser et al., "Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome", CL DIAG LAB, 7(1), 2000, pp. 119-121
8. Locker, GJ; Stoiser, B; Losert, H; Wenzel, C; Ohler, L; Kabrna, E; Geissler, K
   Decrease of circulating hematopoietic progenitor cells during interleukin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion
   LEUKEMIA & LYMPHOMA
   
   G.J. Locker et al., "Decrease of circulating hematopoietic progenitor cells during interleukin-2 treatment is associated with an increase of vascular cell adhesion molecule-1, a critical molecule for progenitor cell adhesion", LEUK LYMPH, 39(3-4), 2000, pp. 355-364
9. Schmidinger, M; Steger, GG; Budinsky, AC; Wenzel, C; Brodowicz, T; Locker, GJ; Kramer, G; Marberger, M; Zielinski, CC
   Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma
   ANTI-CANCER DRUGS
   
   M. Schmidinger et al., "Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma", ANTI-CANC D, 11(3), 2000, pp. 175-179
10. Locker, GJ; Mader, RM; Steiner, B; Wenzl, E; Zielinski, CC; Steger, GG
    Benefit of interferon-alpha(2b) in a patient with unresectable hepatoma and chronic infection with hepatitis C virus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    G.J. Locker et al., "Benefit of interferon-alpha(2b) in a patient with unresectable hepatoma and chronic infection with hepatitis C virus", EUR J GASTR, 12(2), 2000, pp. 251-253
11. Locker, GJ; Grimm, M; Losert, H; Stoiser, B; Kofler, J; Knapp, S; Wilfing, A; Knoebl, P; Kapiotis, S; Czerny, M; Muhm, M; Hiesmayr, M; Frass, M
    Prostaglandin E-1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting
    JOURNAL OF CLINICAL ANESTHESIA
    
    G.J. Locker et al., "Prostaglandin E-1 does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass grafting", J CLIN ANES, 12(5), 2000, pp. 363-370
12. Schmidinger, M; Steger, GG; Wenzel, C; Locker, GJ; Brodowicz, T; Budinsky, AC; Wiltschke, C; Kramer, G; Marberger, M; Zielinski, CC
    Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    M. Schmidinger et al., "Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial", CANCER IMMU, 49(7), 2000, pp. 395-400
13. Staudinger, T; Stoiser, B; Mullner, M; Locker, GJ; Laczika, K; Knapp, S; Burgmann, H; Wilfing, A; Kofler, J; Thalhammer, F; Frass, M
    Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
    CRITICAL CARE MEDICINE
    
    T. Staudinger et al., "Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit", CRIT CARE M, 28(5), 2000, pp. 1322-1328
14. Schmidinger, M; Budinsky, AC; Wenzel, C; Piribauer, M; Brix, R; Kautzky, M; Oder, W; Locker, GJ; Zielinski, CC; Steger, GG
    Glutathione in the prevention of cisplatin induced toxicities - A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer
    WIENER KLINISCHE WOCHENSCHRIFT
    
    M. Schmidinger et al., "Glutathione in the prevention of cisplatin induced toxicities - A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer", WIEN KLIN W, 112(14), 2000, pp. 617-623
15. Locker, GJ; Steger, GG; Gnant, MFX; Steiner, B; Simonitsch, I; Krainer, M; Budinsky, A; Brodowicz, T; Spitzauer, S; Jakesz, R; Zielinski, CC
    Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?
    JOURNAL OF IMMUNOTHERAPY
    
    G.J. Locker et al., "Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?", J IMMUNOTH, 22(1), 1999, pp. 85-89
16. Staudinger, T; Frass, M; Rintelen, C; Quehenberger, P; Wagner, O; Stoiser, B; Locker, GJ; Laczika, K; Knapp, S; Watzke, H
    Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
    INTENSIVE CARE MEDICINE
    
    T. Staudinger et al., "Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients", INTEN CAR M, 25(10), 1999, pp. 1105-1110
17. Thalhammer, F; Traunmuller, F; El Menyawi, I; Frass, M; Hollenstein, UM; Locker, GJ; Stoiser, B; Staudinger, T; Thalhammer-Scherrer, R; Burgmann, H
    Continuous infusion versus intermittent administration of meropenem in critically ill patients
    Journal of antimicrobial chemotherapy
    
    F. Thalhammer et al., "Continuous infusion versus intermittent administration of meropenem in critically ill patients", J ANTIMICRO, 43(4), 1999, pp. 523-527
18. Stoiser, B; Vorbeck, F; Kofler, J; Locker, GJ; Burgmann, H
    Placement of a pulmonary artery catheter via a previously unrecognized persistent left superior vena cava
    VASA-JOURNAL OF VASCULAR DISEASES
    
    B. Stoiser et al., "Placement of a pulmonary artery catheter via a previously unrecognized persistent left superior vena cava", VASA, 28(1), 1999, pp. 53-54
19. Wenzel, C; Schmidinger, M; Locker, GJ; Taucher, S; Gnant, M; Jakesz, R; Steger, GG
    Clinical phase II evaluation of the combination therapy with Docetaxel andEpidoxorubicin in the neoadjuvant, cytostatic treatment on patients with primary breast cancer (T1-4, N0-2, M0)
    WIENER KLINISCHE WOCHENSCHRIFT
    
    C. Wenzel et al., "Clinical phase II evaluation of the combination therapy with Docetaxel andEpidoxorubicin in the neoadjuvant, cytostatic treatment on patients with primary breast cancer (T1-4, N0-2, M0)", WIEN KLIN W, 111(20), 1999, pp. 843-850
20. Locker, GJ; Mader, RM; Rizovski, B; Knapp, S; Domanovits, H; Muellner, M; Hoeller, C; Steger, GG; Sterz, F; Freissmuth, M; Frass, M; Laggner, AN
    Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: Hemodynamic and pharmacokinetic interactions
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    G.J. Locker et al., "Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: Hemodynamic and pharmacokinetic interactions", J PHARM EXP, 290(1), 1999, pp. 43-50
21. Locker, GJ; Kapiotis, S; Veitl, M; Mader, RM; Stoiser, B; Kofler, J; Sieder, AE; Rainer, H; Steger, GG; Mannhalter, C; Wagner, OF
    Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders
    BRITISH JOURNAL OF HAEMATOLOGY
    
    G.J. Locker et al., "Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders", BR J HAEM, 105(4), 1999, pp. 912-919
22. Kettner, SC; Panzer, OP; Kozek, SA; Seibt, FA; Stoiser, B; Kofler, J; Locker, GJ; Zimpfer, M
    Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery
    ANESTHESIA AND ANALGESIA
    
    S.C. Kettner et al., "Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery", ANESTH ANAL, 89(3), 1999, pp. 580-584
23. LOCKER GJ; STAUDINGER T; KNAPP S; BURGMANN H; LACZIKA KF; ZIMMERL M; HORMANN M; FRASS MRM
    ASSESSMENT OF THE PROPER DEPTH OF ENDOTRACHEAL-TUBE PLACEMENT WITH THE TRACHLIGHT
    Journal of clinical anesthesia
    
    G.J. Locker et al., "ASSESSMENT OF THE PROPER DEPTH OF ENDOTRACHEAL-TUBE PLACEMENT WITH THE TRACHLIGHT", Journal of clinical anesthesia, 10(5), 1998, pp. 389-393
24. THALHAMMER F; HOLLENSTEIN UM; LOCKER GJ; JANATA K; SUNDERPLASSMANN G; FRASS M; BURGMANN H
    AZITHROMYCIN-RELATED TOXIC EFFECTS OF DIGITOXIN
    British journal of clinical pharmacology
    
    F. Thalhammer et al., "AZITHROMYCIN-RELATED TOXIC EFFECTS OF DIGITOXIN", British journal of clinical pharmacology, 45(1), 1998, pp. 91-92
25. STAUDINGER T; MULLNER M; WAGNER A; LOCKER GJ; LACZIKA K; KNAPP S; BURGMANN H; STOISER B; KOFLER J; FRASS M
    EXPERIENCES WITH INHALATIVE NITRIC-OXIDE IN INTERNAL INTENSIVE-CARE PATIENTS WITH ARDS
    Acta medica austriaca
    
    T. Staudinger et al., "EXPERIENCES WITH INHALATIVE NITRIC-OXIDE IN INTERNAL INTENSIVE-CARE PATIENTS WITH ARDS", Acta medica austriaca, 25(2), 1998, pp. 53-56
26. STAUDINGER T; KORDOVA H; ROGGLA M; TESINSKY P; LOCKER GJ; LACZIKA K; KNAPP S; FRASS M
    COMPARISON OF OXYGEN COST OF BREATHING WITH PRESSURE-SUPPORT VENTILATION AND BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE VENTILATION
    Critical care medicine
    
    T. Staudinger et al., "COMPARISON OF OXYGEN COST OF BREATHING WITH PRESSURE-SUPPORT VENTILATION AND BIPHASIC INTERMITTENT POSITIVE AIRWAY PRESSURE VENTILATION", Critical care medicine, 26(9), 1998, pp. 1518-1522
27. LOCKER GJ; BURGMANN H; STAUDINGER T; KNAPP S; LACZIKA KF; FRASS M
    CARDIAC SIDE-EFFECTS OF L-NNMA - REPLY
    Critical care medicine
    
    G.J. Locker et al., "CARDIAC SIDE-EFFECTS OF L-NNMA - REPLY", Critical care medicine, 26(1), 1998, pp. 190-191
28. KNAPP S; THALHAMMER F; LOCKER GJ; LACZIKA K; HOLLENSTEIN U; FRASS M; WINKLER S; STOISER B; WILFING A; BURGMANN H
    PROGNOSTIC VALUE OF MIP-1-ALPHA, TGF-BETA(2), SELAM-1, AND SVCAM-1 INPATIENTS WITH GRAM-POSITIVE SEPSIS
    Clinical immunology and immunopathology
    
    S. Knapp et al., "PROGNOSTIC VALUE OF MIP-1-ALPHA, TGF-BETA(2), SELAM-1, AND SVCAM-1 INPATIENTS WITH GRAM-POSITIVE SEPSIS", Clinical immunology and immunopathology, 87(2), 1998, pp. 139-144
29. STOISER B; KNAPP S; THALHAMMER F; LOCKER GJ; KOFLER J; HOLLENSTEIN U; STAUDINGER T; WILFING A; FRASS M; BURGMANN H
    TIME-COURSE OF IMMUNOLOGICAL MARKERS IN PATIENTS WITH THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - EVALUATION OF SCD14, SVCAM-1, SELAM-1, MIP-1-ALPHA AND TGF-BETA-2
    European journal of clinical investigation
    
    B. Stoiser et al., "TIME-COURSE OF IMMUNOLOGICAL MARKERS IN PATIENTS WITH THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - EVALUATION OF SCD14, SVCAM-1, SELAM-1, MIP-1-ALPHA AND TGF-BETA-2", European journal of clinical investigation, 28(8), 1998, pp. 672-678
30. STAUDINGER T; LOCKER GJ; LACZIKA K; KNAPP S; BURGMANN H; WAGNER A; WEISS K; ZIMMERL M; STOISER B; FRASS M
    DIAGNOSTIC VALIDITY OF PULMONARY-ARTERY CATHETERIZATION FOR RESIDENTSAT AN INTENSIVE-CARE UNIT
    The journal of trauma, injury, infection, and critical care
    
    T. Staudinger et al., "DIAGNOSTIC VALIDITY OF PULMONARY-ARTERY CATHETERIZATION FOR RESIDENTSAT AN INTENSIVE-CARE UNIT", The journal of trauma, injury, infection, and critical care, 44(5), 1998, pp. 902-906
31. LACZIKA K; KNAPP S; LOCKER GJ; THALHAMMER F; STOISER B; FRASS M; BURGMANN H
    TREMENDOUS HIGH PLASMA LIPOPOLYSACCHARIDE CONCENTRATIONS IN A PATIENTWITH LEGIONELLA-PNEUMOPHILA PNEUMONIA
    Journal of endotoxin research
    
    K. Laczika et al., "TREMENDOUS HIGH PLASMA LIPOPOLYSACCHARIDE CONCENTRATIONS IN A PATIENTWITH LEGIONELLA-PNEUMOPHILA PNEUMONIA", Journal of endotoxin research, 4(4), 1997, pp. 301-304
32. STAUDINGER T; BANKIER A; STROHMAIER W; WEISS K; LOCKER GJ; KNAPP S; ROGGLA M; LACZIKA K; FRASS M
    EXOGENOUS SURFACTANT THERAPY IN A PATIENT WITH ADULT-RESPIRATORY-DISTRESS-SYNDROME AFTER NEAR-DROWNING
    Resuscitation
    
    T. Staudinger et al., "EXOGENOUS SURFACTANT THERAPY IN A PATIENT WITH ADULT-RESPIRATORY-DISTRESS-SYNDROME AFTER NEAR-DROWNING", Resuscitation, 35(2), 1997, pp. 179-182
33. STAUDINGER T; ROGGLA M; KETTENBACH J; DEKAN G; LOCKER GJ; KNAPP S; LACZIKA K; ZIMMERL M; GRANINGER W; FRASS M
    RESPIRATORY-FAILURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DECISIVE DIFFERENTIATION BETWEEN ACUTE PNEUMONITIS AND INFECTION
    British journal of rheumatology
    
    T. Staudinger et al., "RESPIRATORY-FAILURE IN SYSTEMIC LUPUS-ERYTHEMATOSUS - DECISIVE DIFFERENTIATION BETWEEN ACUTE PNEUMONITIS AND INFECTION", British journal of rheumatology, 36(2), 1997, pp. 295-297
34. SUNDERPLASSMANN G; LOCKER GJ; MUHM M; THALHAMMER F; LACZIKA K; VONFRIEDENFELDT MF
    CENTRAL VENOUS CATHETERIZATION IN A PATIENT IN THE PRONE POSITION
    Critical care medicine
    
    G. Sunderplassmann et al., "CENTRAL VENOUS CATHETERIZATION IN A PATIENT IN THE PRONE POSITION", Critical care medicine, 25(8), 1997, pp. 1439-1440
35. LACZIKA K; STAUDINGER T; HOLLENSTEIN U; PRESTERL E; LOCKER GJ; KNAPP S; BURGMANN H; STOISER B; KOFLER J; WINTER W; GRANINGER W; FRASS M
    RENAL TOLERABILITY OF 4 DIFFERENT ONCE-DAILY DOSE REGIMEN OF NETILMICIN IN CRITICAL CARE PATIENTS
    Wiener Klinische Wochenschrift
    
    K. Laczika et al., "RENAL TOLERABILITY OF 4 DIFFERENT ONCE-DAILY DOSE REGIMEN OF NETILMICIN IN CRITICAL CARE PATIENTS", Wiener Klinische Wochenschrift, 109(21), 1997, pp. 840-844
36. KRAFFT P; ROGGLA M; FRIDRICH P; LOCKER GJ; FRASS M; BENUMOF JL
    BRONCHOSCOPY VIA A REDESIGNED COMBITUBE(TM) IN THE ESOPHAGEAL POSITION - A CLINICAL-EVALUATION
    Anesthesiology
    
    P. Krafft et al., "BRONCHOSCOPY VIA A REDESIGNED COMBITUBE(TM) IN THE ESOPHAGEAL POSITION - A CLINICAL-EVALUATION", Anesthesiology, 86(5), 1997, pp. 1041-1045
37. THALHAMMER F; HOLLENSTEIN U; JANATA K; KNAPP S; KOLLER R; LOCKER GJ; STAUDINGER T; SUNDERPLASSMANN G; FRASS M; BURGMANN H
    A COINCIDENCE OF DISASTROUS ACCIDENTS - CROHNS-DISEASE, AGRANULOCYTOSIS, AND CLOSTRIDIUM-SEPTICUM INFECTION
    The journal of trauma, injury, infection, and critical care
    
    F. Thalhammer et al., "A COINCIDENCE OF DISASTROUS ACCIDENTS - CROHNS-DISEASE, AGRANULOCYTOSIS, AND CLOSTRIDIUM-SEPTICUM INFECTION", The journal of trauma, injury, infection, and critical care, 43(3), 1997, pp. 556-557
38. LOCKER GJ; STAUDINGER T; KNAPP S; LACZIKA KF; BURGMANN H; URLICIC A; WAGNER A; METNITZ P; KNOEBL P; SCHUSTER E; FRASS M
    PROSTAGLANDIN E(1) INHIBITS PLATELET DECREASE AFTER MASSIVE BLOOD-TRANSFUSIONS DURING MAJOR SURGERY - INFLUENCE ON COAGULATION CASCADE
    The journal of trauma, injury, infection, and critical care
    
    G.J. Locker et al., "PROSTAGLANDIN E(1) INHIBITS PLATELET DECREASE AFTER MASSIVE BLOOD-TRANSFUSIONS DURING MAJOR SURGERY - INFLUENCE ON COAGULATION CASCADE", The journal of trauma, injury, infection, and critical care, 42(3), 1997, pp. 525-531
39. STAUDINGER T; PRESTERL E; GRANINGER W; LOCKER GJ; KNAPP S; LACZIKA K; KLAPPACHER G; STOISER B; WAGNER A; TESINSKY P; KORDOVA H; FRASS M
    INFLUENCE OF PENTOXIFYLLINE ON CYTOKINE LEVELS AND INFLAMMATORY PARAMETERS IN SEPTIC SHOCK
    Intensive care medicine
    
    T. Staudinger et al., "INFLUENCE OF PENTOXIFYLLINE ON CYTOKINE LEVELS AND INFLAMMATORY PARAMETERS IN SEPTIC SHOCK", Intensive care medicine, 22(9), 1996, pp. 888-893
40. STAUDINGER T; LOCKER GJ; FRASS M; KALHS P
    MISLEADING HIGH VALUES OF OXYGEN-SATURATION MEASURED BY PULSE OXIMETRY IN EXCESSIVE HYPERBILIRUBINEMIA AFTER BMT
    Bone marrow transplantation
    
    T. Staudinger et al., "MISLEADING HIGH VALUES OF OXYGEN-SATURATION MEASURED BY PULSE OXIMETRY IN EXCESSIVE HYPERBILIRUBINEMIA AFTER BMT", Bone marrow transplantation, 18(5), 1996, pp. 1025-1025
41. STAUDINGER T; LOCKER GJ; FRASS M
    MANAGEMENT OF ACQUIRED COAGULATION DISORDERS IN EMERGENCY AND INTENSIVE-CARE MEDICINE
    Seminars in thrombosis and hemostasis
    
    T. Staudinger et al., "MANAGEMENT OF ACQUIRED COAGULATION DISORDERS IN EMERGENCY AND INTENSIVE-CARE MEDICINE", Seminars in thrombosis and hemostasis, 22(1), 1996, pp. 93-104
42. LOCKER GJ; BURGMANN H; STAUDINGER T; KNAPP S; LACZIKA KF; FRASS M
    FATAL CARDIAC SIDE-EFFECTS OF L-NMMA
    Critical care medicine
    
    G.J. Locker et al., "FATAL CARDIAC SIDE-EFFECTS OF L-NMMA", Critical care medicine, 24(11), 1996, pp. 1930-1930
43. BURGMANN H; WINKLER S; LOCKER GJ; PRESTERL E; LACZIKA K; STAUDINGER T; KNAPP S; THALHAMMER F; WENISCH C; ZEDWITZLIEBENSTEIN K; FRASS M; GRANINGER W
    INCREASED SERUM CONCENTRATION OF SOLUBLE CD14 IS A PROGNOSTIC MARKER IN GRAM-POSITIVE SEPSIS
    Clinical immunology and immunopathology
    
    H. Burgmann et al., "INCREASED SERUM CONCENTRATION OF SOLUBLE CD14 IS A PROGNOSTIC MARKER IN GRAM-POSITIVE SEPSIS", Clinical immunology and immunopathology, 80(3), 1996, pp. 307-310
44. WAGNER A; STAUDINGER T; KOFLER J; KEIL F; ROGGLA G; ROGGLA M; LOCKER GJ; KALHS P; MULLNER M; BINDER M; FRASS M
    RESULTS OF INTENSIVE-CARE UNIT SUPPORT OF PATIENTS AFTER BONE-MARROW TRANSPLANTATION
    Wiener Klinische Wochenschrift
    
    A. Wagner et al., "RESULTS OF INTENSIVE-CARE UNIT SUPPORT OF PATIENTS AFTER BONE-MARROW TRANSPLANTATION", Wiener Klinische Wochenschrift, 108(21), 1996, pp. 677-682
45. LOCKER GJ; KOTZMANN H; FREY B; MESSINA FC; STERZ FR; WEISSEL M; LAGGNER AN
    FACTITIOUS HYPERTHYROIDISM CAUSING ACUTE MYOCARDIAL-INFARCTION
    Thyroid
    
    G.J. Locker et al., "FACTITIOUS HYPERTHYROIDISM CAUSING ACUTE MYOCARDIAL-INFARCTION", Thyroid, 5(6), 1995, pp. 465-467
46. WAGNER A; ROEGGLA M; ROEGGLA G; WEISS K; MAROSI C; LOCKER GJ; KNAPP S; STAUDINGER T; METNITZ PGH; FRASS M
    EMERGENCY INTUBATION WITH THE COMBITUBE IN A CASE OF SEVERE FACIAL BURN
    The American journal of emergency medicine
    
    A. Wagner et al., "EMERGENCY INTUBATION WITH THE COMBITUBE IN A CASE OF SEVERE FACIAL BURN", The American journal of emergency medicine, 13(6), 1995, pp. 681-683
47. LOCKER GJ; SIMONITSCH I; MADER RM; WARLAMIDES E; GNANT MFX; JAKESZ R; RAINER H; STEGER GG
    CUTANEOUS SIDE-EFFECTS IN BREAST-CANCER PATIENTS TREATED WITH CYTOSTATIC POLYCHEMOTHERAPY AND RH GM-CSF - IMMUNE PHENOMENA OR DRUG TOXICITY
    Breast cancer research and treatment
    
    G.J. Locker et al., "CUTANEOUS SIDE-EFFECTS IN BREAST-CANCER PATIENTS TREATED WITH CYTOSTATIC POLYCHEMOTHERAPY AND RH GM-CSF - IMMUNE PHENOMENA OR DRUG TOXICITY", Breast cancer research and treatment, 34(3), 1995, pp. 213-219
48. LACZIKA K; STAUDINGER T; LOCKER GJ; KNAPP S; BURGMANN H; FRASS M
    TETRIS AND PHYSICIANS PERFORMANCE STATE
    Lancet
    
    K. Laczika et al., "TETRIS AND PHYSICIANS PERFORMANCE STATE", Lancet, 346(8973), 1995, pp. 516-516
49. LOCKER GJ; MADER RM; BRAUN J; SIEDER AE; MAROSI C; RAINER H; JAKESZ R; STEGER GG
    NEW MUCIN-LIKE CANCER-ASSOCIATED ANTIGENS (CA-M-26, CA-M-29 AND CA-549) AND A NEW PROLIFERATION MARKER (TPS) IN PATIENTS WITH PRIMARY OR ADVANCED BREAST-CANCER
    Oncology
    
    G.J. Locker et al., "NEW MUCIN-LIKE CANCER-ASSOCIATED ANTIGENS (CA-M-26, CA-M-29 AND CA-549) AND A NEW PROLIFERATION MARKER (TPS) IN PATIENTS WITH PRIMARY OR ADVANCED BREAST-CANCER", Oncology, 52(2), 1995, pp. 140-144
50. WAGNER A; MAROSI C; BINDER M; ROGGLA G; STAUDINGER T; KEIL F; LOCKER GJ; FRASS M
    FATAL POISONING DUE TO DAPSONE IN A PATIENT WITH GROSSLY ELEVATED METHEMOGLOBIN LEVELS
    British journal of dermatology
    
    A. Wagner et al., "FATAL POISONING DUE TO DAPSONE IN A PATIENT WITH GROSSLY ELEVATED METHEMOGLOBIN LEVELS", British journal of dermatology, 133(5), 1995, pp. 816-817
51. LOCKER GJ; WAGNER A; PETER A; STAUDINGER T; MAROSI C; RINTELEN C; KNAPP S; MALZER R; WEISS K; METNITZ P; FRASS M
    LETHAL WATERHOUSE-FRIDERICHSEN SYNDROME IN POSTTRAUMATIC ASPLENIA
    The journal of trauma, injury, infection, and critical care
    
    G.J. Locker et al., "LETHAL WATERHOUSE-FRIDERICHSEN SYNDROME IN POSTTRAUMATIC ASPLENIA", The journal of trauma, injury, infection, and critical care, 39(4), 1995, pp. 784-786